Electrophoresis Reagents Market

Global Electrophoresis Reagents Market Size (2022 to 2027)

Between 2023 to 2028, the size of the global electrophoresis reagents market is expected to rise at a CAGR of 6.54%

Electrophoresis is a laboratory technique for separating protein, RNA, or DNA molecules using an electric current. Agarose gels, TBE buffers, Bromophenol Blue, and Starch gels are the most common reagents used in electrophoresis, and various healthcare facilities employ electrophoresis for DNA and RNA analysis and protein analysis. Electrophoresis is used to analyze lipoproteins and apolipoproteins, which are essential for determining the severity of cardiovascular diseases and monitoring patients during treatment. Electrophoresis separates proteins depending on their size, purity, and density. This technique's ease of use allows it to be used in various applications, including hemoglobinopathies diagnosis, vaccination analysis, antibody analysis, and medicine quality control.

Impact of COVID-19 on the global electrophoresis reagents market:

The rising prevalence of COVID-19 infection is predicted to fuel demand for electrophoresis devices that aid in detecting the virus using RT-PCR tests. These tests will aid in reducing virus spread by providing precise results, which is projected to propel the electrophoresis reagents market forward throughout the forecast period. The COVID-19 outbreak was a public health disaster unlike any other, affecting nearly every industry. Because the electrophoresis technique has been utilized to develop effective therapeutics for COVID-19, the pandemic has had a beneficial impact on market growth. It is used to separate DNA, RNA, or protein molecules according to their size to develop effective medicines for COVID-19. COVID-19 has had a favorable impact on research and development efforts in the medical, pharmaceutical, and biochemistry fields, which has aided the electrophoresis reagent market's growth.

MARKET DRIVERS:

The electrophoresis market has seen significant expansion, a fast-growing elderly population, increased funding for genomics research, and quick technological advancement in recent years, which has had a favorable impact on the overall growth of the global electrophoresis reagents market.

The market for electrophoresis reagents has seen new changes and novel applications. Increasing rates of infectious diseases, cancer, and genetic disorders are expected to boost research funding from local governments in several countries, as well as private funding from pharmaceutical and biotechnology companies, for the development of effective biologics for treating these diseases, which is expected to boost demand for electrophoresis reagents over the forecast period. In clinical laboratories, electrophoresis is used to measure lipoproteins utilizing enzymatic cholesterol and triglyceride labeling to diagnose CVD and other disorders.

In the near future, demand for electrophoresis reagents is likely to rise due to increased research and development activities in developing effective medicines. The global electrophoresis market is growing due to increased usage of next-generation sequencing, industry-academic cooperation, and increased government support for electrophoresis research. In addition, the opportunities for the market are created by rising demand for personalized treatment and a focus on proteomics research. The market for electrophoresis reagents is further predicted to grow in the future as the requirement for diagnostics grows due to the spread of chronic diseases.

MARKET RESTRAINTS:

The advent of competing technologies offering higher efficiency and results and time-consuming processes, and limited sample analysis through gel electrophoresis are limiting the growth of this market to some extent. In addition, the electrophoresis reagents market has a challenge due to a lack of suitable rules and quality requirements for the manufacture of reagents. The growth of the electrophoresis reagents market is further expected to be hampered by a lack of suitable hospitals, doctors, research institutions, and pharmaceutical companies in low and middle-income nations, which are some of the product's key end customers.

REPORT COVERAGE:

This report on the global electrophoresis reagents market has been segmented and sub-segmented into the following categories.

Electrophoresis Reagents Market – By Product:

• Dyes
• Gels
• Buffers
• Others

Based on the product, the gels segment led the global electrophoresis reagents market in 2022. Low operating and equipment costs, increased applications in the pharmaceutical and biotechnology industries, and the rising burden of infectious diseases, cancer, and genetic abnormalities are all propelling the gel segment. Gel electrophoresis is a technique for separating and analyzing macromolecules, including RNA, DNA, and proteins and their fragments, based on charge and size. It's used to separate proteins in clinical chemistry, and it's also used in molecular biology and biochemistry to separate a mixed population of RNA and DNA fragments by length, among other things. As a result of the factors mentioned, the segment is predicted to expand in the next few years.

Electrophoresis Reagents Market – By Application:

• Protein Analysis
• DNA & RNA Analysis

The protein analysis market held the largest share of the market in 2022. Factors can be ascribed to the pharmaceutical and biotechnology industries' increased attention on proteomics research. Because of the rising research and development efforts in the medical and pharmaceutical industries, protein analysis is expected to maintain its market dominance over electrophoresis.

Electrophoresis Reagents Market – By End-User:

• Academic & Research Institutions
• Pharmaceutical & Biotech Companies
• Hospitals & Diagnostic Centers

Because of the increase in private and public R&D expenditure, the Pharmaceutical & Biotechnological Companies segment held the most outstanding share of the market. The Covid-19 epidemic and the introduction of new virus types are to blame. The ability of electrophoresis to separate DNA and RNA is critical in viral research and the development of effective antiviral treatments.

Electrophoresis Reagents Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

The fastest-growing market is predicted to be in Asia-Pacific. There has been an increase in the number of research activities going on in academic and research institutions, as well as pharmaceutical and biotechnology companies, in the emerging economies of China, Japan, and India, and increasing adoption of advanced technology and rising health awareness are some of the key factors contributing to market growth. For example, Japanese scientists have devised a new way to identify single virus particles based on changes in electrical current through the electrophoresis process. Furthermore, capillary electrophoresis in fields such as microbial detection and protein analysis is enhancing the popularity of the technology and propelling the market forward.

Because of the region's highly developed healthcare infrastructure, rising incidences of chronic and infectious diseases, and growing geriatric population, the North American segment is expected to dominate the electrophoresis reagents market with a market share during the forecast period.

Due to market players and research institutes' increased research and development initiatives, Europe is likely to see considerable growth in the electrophoresis reagents market.

KEY MARKET PLAYERS:

Companies playing a leading role in the global electrophoresis reagents market profiled in this report are Sigma-Aldrich Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck Millipore, GE Healthcare, Agilent Technologies, Inc., Lonza Group, AG, Takara Bio, Inc., and Harvard Bioscience, Inc.

RECENT HAPPENINGS IN THIS MARKET:

• Hitachi High-Tech Corporation announced that the Hitachi DS3000 small capillary electrophoresis (CE) sequencer is now available for purchase through local agents in Japan, China, South Korea, and Taiwan. Hitachi High-Tech Corporation and Promega Corporation collaborated on the Hitachi DS3000, which was released in 2020.
• In 2021, capillary electrophoresis to be used to establish a rapid and cost-effective way of detecting recognized variations of concern, allowing local facilities to screen for and track SARS-CoV-2 variants of concern and adopt reactive treatments.